MiMedx Group Inc. (NASDAQ:MDXG) said it will treat four resignations announced this summer, including that of former Chairman and CEO Parker Petit, as "for cause" terminations. The regenerative medicine and biologics company said the decision, made by ...

Management tracks: Ex-MiMedx execs to lose compensation and more...

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Management tracks: Ex-MiMedx execs to lose compensation

MiMedx Group Inc. (NASDAQ:MDXG) said it will treat four resignations announced this summer, including that of former Chairman and CEO Parker Petit, as "for cause" terminations. The regenerative medicine and biologics company said the decision, made by the board and compensation committee, was based on an independent investigation by its audit committee that found "the ex-employees engaged in, among other things, conduct detrimental to the business and reputation of the Company."

      
 

Boston Scientific launches LithoVue Empower kidney stone retrieval device

Boston Scientific (NYSE:BSX) said today it launched its LithoVue Empower retrieval deployment device designed to be used with the LithoVue single-use digital flexible ureteroscope during ureteroscopic kidney stone retrieval procedures.

      
 

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug

Equillium, a biotech startup developing treatments for immune system disorders—including an immune response that affects some transplant recipients—is preparing for an IPO to finance tests of its lead drug.

      
 

Why Corbus Pharmaceuticals Holdings Inc. Tumbled Today

Shares of Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) were down 18.6% as of 11:50 a.m. EDT on Friday. The big tumble followed yesterday's huge gain, which stemmed from news that the clinical-stage biotech made a deal for exclusive worldwide rights to develop and market drugs based on more than 600 compounds targeting the endocannabinoid system.

      
 

Judge slaps lawyers with $1.4m in fines over $645m KCI trade theft case

A federal judge this week slapped lawyers representing Healthcare Essentials in a trade theft lawsuit brought by Acelity subsidiary Kinetic Concepts Inc. with some $1.4 million in fines for their part in the case.

      
 

Contact Us

Past Issues

Unsubscribe